EichorEICHOR
Condition: Human Immunodeficiency Virus I Infection Synced from ClinicalTrials.gov · August 07, 2026

Recruiting studies: Human Immunodeficiency Virus I Infection

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

Low Dose Nivolumab in Adults Living With HIV on Antiretroviral Therapy
Phase 1/Phase 2 · 2 location(s) · University of Melbourne · NCT05187429HIV Therapeutic DNA Vaccine (ICVAX) Phase I Clinical Trial in Hong Kong
Phase 1 · 1 location(s) · Immuno Cure Holding (HK) Limited · NCT07530198Evaluation of Safety and Immunogenicity of Ad26.Mos4.HIV and CH505 TF chTrimer Combination in Healthy Adults
Phase 1 · 1 location(s) · U.S. Army Medical Research and Development Command · NCT06205056Real World Use of Lenacapavir, as an add-on to an Optimized Background Regimen in France
Phase N/A · 1 location(s) · Centre de Recherches et d'Etude sur la Pathologie Tropicale · NCT06799338Reactive Driven Support for Treatment, Adherence, Resilience, and Thriving (reSTART) Clinical Trial
NA · 1 location(s) · University of California, San Francisco · NCT07125235Administration of Venetoclax to Promote Apoptosis of HIV-infected Cells and Reduce the Size of the HIV Reservoir Among P
Phase 1/Phase 2 · 1 location(s) · University of Aarhus · NCT05668026A Clinical Trial Investigating the Safety and Biological Activity of the Antibody BNT351 in Adults Living Without and Wi
Phase 1 · 6 location(s) · BioNTech SE · NCT07392372Impact of Pain From Injectables Antiretroviral Treatments in HIV-1 Patients Based on the Injection Site (Ventrogluteal o
NA · 5 location(s) · Centre Hospitalier Régional d'Orléans · NCT06834113A Study to Investigate Pharmacokinetics, Safety and Tolerability of Long-Acting Cabotegravir Plus Recombinant Human Hyal
Phase 1 · 3 location(s) · ViiV Healthcare · NCT05418868Very Early Intensive Treatment of Infants Living With HIV to Achieve HIV Remission
Phase 1/Phase 2 · 46 location(s) · National Institute of Allergy and Infectious Diseases (NIAID · NCT02140255Evaluation of Safety, Immunogenicity and Efficacy of a Triple Immune Regimen in Adults Initiated on ART During Acute HIV
Phase 1/Phase 2 · 12 location(s) · National Institute of Allergy and Infectious Diseases (NIAID · NCT06071767Evaluating the Safety and Immunogenicity of MTBVAC
Phase 2 · 16 location(s) · HIV Vaccine Trials Network · NCT05947890Project I Test: Implementing HIV Testing in Opioid Treatment Programs
NA · 1 location(s) · Columbia University · NCT03135886Evaluation of Patients With HAM/TSP
Phase N/A · 1 location(s) · National Institute of Neurological Disorders and Stroke (NIN · NCT00001778Trial of Allogeneic Reduced-Intensity, HLA-Haploidentical Allogeneic Hematopoietic Cell Bone Marrow Transplantation Foll
Phase 1/Phase 2 · 1 location(s) · National Cancer Institute (NCI) · NCT05470491Tnf Inhibitors to Reduce Mortality in HIV-1 Infected PAtients With Tuberculosis meNIngitis
Phase 2 · 3 location(s) · ANRS, Emerging Infectious Diseases · NCT05590455
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →
Eichor
Clinical intelligence from public evidence
Use of Eichor is governed by our Terms of Use · Privacy Policy
© 2026 Biomedistats LLC (dba Eichor)

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.